Tag Archive
Arrowhead seeks to regain Nasdaq compliance (Whittier Daily News)
PASADENA - Arrowhead Research Corp., a nanotechnology company that commercializes new technologies, has received another 180-day grace period to regain compliance with Nasdaq Capital Market’s $1 minimum bid requirement. (read the story…) Related items Arrowhead Receives Additional 180-Day Grace Period to Comply with the NASDAQ $1.00 Minimum Bid Requirement (Business Wire via Yahoo! Finance) Arrowhead Reports Fiscal 2009... »
Arrowhead Receives Additional 180-Day Grace Period to Comply with the NASDAQ $1.00 Minimum Bid Requirement (Business Wire via Yahoo! Finance)
PASADENA, Calif.—-Arrowhead Research Corporation today announced that, on March 16, 2010, it received a notification from the NASDAQ Stock Market indicating that the Company will have an additional 180-day grace period, until September 13, 2010, to regain compliance with NASDAQ’s $1.00 minimum bid requirement. (read the story…) Related items Arrowhead seeks to regain Nasdaq compliance (Whittier Daily... »
Arrowhead Reports Fiscal 2010 First Quarter Financial Results (Business Wire via Yahoo! Finance)
PASADENA, Calif.—-Arrowhead Research Corporation today announced financial results for its fiscal 2010 first quarter ended December 31, 2009. (read on…) Related items Arrowhead Research Corporation Subsidiary Tego Biosciences Sells IP Portfolio to Luna Innovations (Business Wire via Yahoo! Finance) Arrowhead Reports Fiscal 2009 Fourth Quarter and Full-Year Financial Results (Business Wire via Yahoo! Finance) Arrowhead Receives Additional 180-Day Grace... »
Arrowhead Appoints Chief Financial Officer (Business Wire via Yahoo! Finance)
PASADENA, Calif.—-Arrowhead Research Corporation today announced that Ken Myszkowski has been appointed as the Company’s Chief Financial Officer. Mr. Myszkowski brings to Arrowhead a broad range of finance and accounting experience spanning two decades in both the public and private sectors, including, most recently, senior level positions at two publicly traded energy companies and,... »
Tego Biosciences sells intellectual property portfolio to Luna Innovations (News-Medical-Net)
Arrowhead Research Corporation today announced that its wholly owned subsidiary, Tego Biosciences, has completed a definitive asset purchase agreement for the sale of its non-cash intellectual property (IP) to Luna Innovations, Inc., a developer and manufacturer of new-generation products that include pharmaceutical nanomedicines (read the story…) Related items Arrowhead Research Corporation Subsidiary Tego Biosciences Sells IP Portfolio... »
